Autoimmune News: Breaking Autoimmune News, Comments and Articles. - Page: 2

BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute

ROCKVILLE, Md. and BALTIMORE, May 20, 2013 /PRNewswire/ -- BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, today announced its selection of Ram Aiyar, Ph.D., M.B.A., as the first Entrepreneur-in-Residence (EIR) for BHI at the National...

Researchers link coffee consumption with reduced risk of primary sclerosing cholangitis

Research presented today at Digestive Disease Week explores new discoveries in liver disease research, with findings about the impact of coffee on autoimmune disease and palliative care for cirrhotic patients.

Coffee Drinking Tied To Lower Risk For Rare Liver Disease PSC

New research from the US shows that regular consumption of coffee is linked to a reduced risk of a rare autoimmune liver disease called primary sclerosing cholangitis (PSC). Study investigator Craig Lammert, a gastroenterologist and hepatologist at...

Table: MS Ventures portfolio

Merck Serono's earnest money MS Ventures portfolio MS Ventures is managing investments in a portfolio of 12 companies working in areas relevant to Merck Serono S.A.'s focus in cancer, autoimmune, neurodegenerative …

Immune System Boosted By Stem-Cell-Based Strategy In Mouse Model

Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory. The researchers showed that, in mice, the tissue can be used to foster the develo...

Clinical Notes: Answer Emerges to MS Drug Puzzle

(MedPage Today) -- The mystery of why a drug for one autoimmune disease can cause another may have been solved. Also this week: a new oral nimodipine formulation aimed at reducing medication errors.

China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart Failure Drug

By ChinaBio Today: Deals and Financings RuiYi Inc., a San Diego-Shanghai biotech startup, has signed an exclusive license and collaboration with Genor BioPharma of Shanghai to develop RuiYi's lead molecule in China. The drug candidate, RYI-008, is a novel anti-IL-6 monoclonal antibody with potential to treat autoimmune diseases and cancer.RuiYi also enlisted CMC Biologics to develop a cell lin...

Coffee Linked To Lower Risk Of Autoimmune Liver Disease

redOrbit Staff & Wire Reports - Your Universe Online Regular coffee consumption has been linked to a reduced risk of the autoimmune liver disease primary sclerosing cholangitis (PSC), according to a study that will be presented by Mayo Clinic researchers at the Digestive Disease Week 2013 conference in Orlando, Florida on Monday. According to the Minnesota-based medical center, PSC is a dise...

Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease Week 2013 conference in Orlan...

Coffee consumption linked to reduced risk of autoimmune liver disease

Research presented today at Digestive Disease Week explores new discoveries in liver disease research, with findings about the impact of coffee on autoimmune disease and palliative care for cirrhotic patients. read more

Consuming coffee linked to lower risk of an autoimmune liver disease

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease.

Study Links Coffee to Lower Risk for Rare Liver Disease

SATURDAY, May 18 (HealthDay News) -- Just a few extra cups of coffee each month might help prevent the development of an autoimmune liver disease known as primary sclerosing cholangitis (PSC), a new study suggests. Investigators from the Mayo Clinic...

Consuming coffee linked to lower risk of detrimental liver disease, Mayo Clinic finds

(Mayo Clinic) Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis, an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease Week 2013 conference...

[AbbVie] pays for option to acquire [Alvine] equity or its celiac disease compound

In an effort to strengthen its existing gastroenterology pipeline, [Abbott]’s spin off [AbbVie Inc.] has paid $70mm up front for the exclusive option to acquire either equity in [Alvine Pharmaceuticals Inc.] (developing therapies autoimmune and inf...

[Ambit] gets $25.1mm through private placement concurrent with IPO close

[Ambit Biosciences Corp.] (kinase inhibitors for cancer, autoimmune, and inflammatory diseases) raised $25.1mm through the private sale of 3.1mm common shares at $8 to existing shareholders. The placement was made concurrent with the closing of Ambit...

RuiYi and Genor BioPharma collaborate on development in China of RYI-008

USA and China-based RuiYi says it has entered into an exclusive license and collaborative development agreement with Genor BioPharma for the development of RYI-008 in China. RYI-008 is a novel anti-Interleukin-6 monoclonal antibody with a unique phar...

Scientists develop potential new treatment for autoimmune diseases

Scientists at Montana State University have developed a therapeutic that has potential as a biological drug or probiotic food product to combat many of the more than 80 autoimmune disorders that affect some 23.5 million people in the United States.

Belgium's Galapagos says on track to meet 2013 guidance

BRUSSELS, May 17 (Reuters) - Galapagos, the Belgian developer of drugs to fight autoimmune diseases such as lupus and rheumatoid arthritis, said it was on track to meet its full-year revenue guidance this year.

UCSF researchers create first functioning human thymus tissue from embryonic stem cells

Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells, in the laboratory. The researchers showed that, in mice, the tissue can be used to foster the devel...

RuiYi and Genor Enter License and Collaboration for Novel mAb

RuiYi Inc., a San Diego-Shanghai biotech startup, has signed an exclusive license and collaboration with Genor BioPharma to develop RuiYi’s lead molecule in China. The drug candidate, RYI-008, is a novel anti-IL-6 monoclonal antibody with poten...

Celiac Disease Awareness Month with Joy Keys

Philadelphia, PA, May 17, 2013 --(PR.com)-- Celiac Disease Awareness Month Celiac disease is an autoimmune digestive disease that damages the villi of the small intestine and interferes with absorption of nutrients from food. Date: May 18th, 2013 Time: 11:00 a.m. - 11:30 a.m. ET Call in number: 646-929-0368 URL: http://www.blogtalkradio.com/joykeys/2013/05/18/celiac-awareness-month-with-joy-...

AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease

NORTH CHICAGO, Ill. and MECHELEN, Belgium, May 17, 2013 /PRNewswire/ -- Galapagos NV (Euronext: GLPG) and AbbVie (NYSE: ABBV) announced today an extension of their GLPG0634 clinical development collaboration to include Crohn's disease.  Galapagos will fund and complete a Phase 2 program in Crohn's disease, which is designed to facilitate rapid progression into Phase 3.  Upon successful c...

Pharmacy Advantage: Going Above and Beyond for Patient Assistance

Locally based Pharmacy Advantage Specialty Pharmacy takes action to innovatively bring about solutions for patients navigating prescription access. As a result of partnerships with national non-profit patient assistance foundations and drug manufacturers, the company's funding department has successfully acquired significantly over one million dollars in copayment support in 2012. Troy, MI (P...

Biogen Idec Foundation Awards $250,000 to East End House to Develop Genetics Education Program

– GenoExplorers Seeks to Introduce Middle School Students to Genetics Concepts Through Interactive Learning – Today the Biogen Idec Foundation announced a $250,000 grant to East End House to develop, implement and evaluate an interactive out-of-school-time (OST) genetics program for middle school youth in Cambridge.

LRI National Patient Coalition Advocacy Culminates in Launch of Federal Provider Education Program

NEW YORK, May 16, 2013 /PRNewswire/ --  The Lupus Research Institute (LRI) National Patient Coalition participated in today's launch of the Lupus Initiative®, the culmination of its five-year advocacy campaign resulting in $4.6 million in Federal funding to make the healthcare provider education program possible. Helping to draw attention to the need addressed by the Initiative to trai...